Author:
Budimirovic Dejan B.,Berry-Kravis Elizabeth,Erickson Craig A.,Hall Scott S.,Hessl David,Reiss Allan L.,King Margaret K.,Abbeduto Leonard,Kaufmann Walter E.
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Neurology (clinical),Pathology and Forensic Medicine,Pediatrics, Perinatology and Child Health
Reference270 articles.
1. Kaufmann WE, Reiss AL. Molecular and cellular genetics of fragile X syndrome. Am J Med Genet. 1999;88:11–24.
2. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, et al. Advances in the treatment of fragile X syndrome. Pediatrics. 2009;123:378–90.
3. Boyle L, Kaufmann WE. The behavioral phenotype of FMR1 mutations. Am J Med Genet. 2010;154C:469–76.
4. Schaefer TL, Davenport MH, Erickson CA. Emerging pharmacologic treatment options for fragile X syndrome. Appl Clin Genet. 2015;8:75–93.
5. Hampson DR, Gholizadeh S, Pacey LKK. Pathways to drug development for autism spectrum disorders. Clin Pharmacol Ther. 2011;91:189–200.
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献